Treatment of woodchuck hepatitis virus infection in vivo with 2', -3'-dideoxycytidine (ddC) and 2',-3'-dideoxycytidine monophosphate coupled to lactosaminated human serum albumin (L-HSA ddCMP). (Q45769212)
Jump to navigation
Jump to search
scientific article published in April 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of woodchuck hepatitis virus infection in vivo with 2', -3'-dideoxycytidine (ddC) and 2',-3'-dideoxycytidine monophosphate coupled to lactosaminated human serum albumin (L-HSA ddCMP). |
scientific article published in April 1996 |
Statements
Treatment of woodchuck hepatitis virus infection in vivo with 2', -3'-dideoxycytidine (ddC) and 2',-3'-dideoxycytidine monophosphate coupled to lactosaminated human serum albumin (L-HSA ddCMP) (English)
woodchuck hepatitis virus
1 reference
F E Zahm
N d'Urso
F Bonino
1 April 1996